Introduction: treatment of Gram-positive infections
Linezolid in vitro: mechanism and antibacterial spectrum
Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections
Efficacy of linezolid versus comparator therapies in Gram-positive infections
Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?
Safety and tolerability of linezolid